Antiatherogenic and antiatherosclerotic effects of mushroom extracts revealed in human aortic intima cell culture
- 1 January 1989
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 17 (2) , 109-117
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Blood serum atherogenicity associated with coronary atherosclerosis. Evidence for nonlipid factor providing atherogenicity of low-density lipoproteins and an approach to its elimination.Circulation Research, 1988
- Evidence of antiatherosclerotic action of verapamil from direct effects on arterial cellsThe American Journal of Cardiology, 1987
- “Regression” of atherosclerosis in cell culture: Effects of stable prostacyclin analoguesDrug Development Research, 1986
- ATHEROGENICITY OF BLOOD SERUM FROM PATIENTS WITH CORONARY HEART DISEASEThe Lancet, 1986
- Primary culture of human aortic intima cells as a model for testing antiatherosclerotic drugs Effects of cyclic AMP, prostaglandins, calcium antagonists, antioxidants, and lipid-lowering agentsAtherosclerosis, 1986
- Lipids in cells of atherosclerotic and uninvolved human aortaExperimental and Molecular Pathology, 1985
- ARTIFICIAL HDL AS AN ANTI-ATHEROSCLEROTIC DRUGThe Lancet, 1984
- PROSTACYCLIN ANALOGUES AS ANTIATHEROSCLEROTIC DRUGSThe Lancet, 1983
- Dibutyryl cyclic AMP decreases proliferative activity and the cholesteryl ester content in cultured cells of atherosclerotic human aortaBiochemical and Biophysical Research Communications, 1982
- Effect of Basidiomycetes on Plasma Cholesterol in RatsEiyo to Shokuryo, 1977